Moolec Science (MLEC) Other Non Operating Income (2022 - 2024)
Moolec Science's (MLEC) quarterly Other Non Operating Income came in at $608520.0 in Q4 2024, up 594.44% year-on-year from $87627.2 in Q1 2024, and down 15.2% quarter-over-quarter from $717573.0 in Q3 2024.
Moolec Science (MLEC) Other Non Operating Income (2022 - 2024) Analysis & Trends
Moolec Science has disclosed Other Non Operating Income across 3 years of filings, most recently posting $608520.0 for Q4 2024.
- Other Non Operating Income for Q4 2024 came in at $608520.0, up 594.44% year-over-year; the trailing twelve-month figure through Dec 2024 was -$7.3 million (up 44.54% YoY), and the FY2024 annual result was -$9.7 million, up 28.74% from the prior year.
- Other Non Operating Income came in at $608520.0 for Q4 2024 at Moolec Science, down from $717573.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $1.1 million in Q1 2024 to a low of -$13.7 million in Q2 2023.
- The 3-year median for Other Non Operating Income is -$3111.0 (2022), against an average of -$3.0 million.
- Peak annual rise in Other Non Operating Income reached 18134.07% in 2023, while the deepest fall reached 15.98% in 2023.
- Moolec Science's Other Non Operating Income stood at -$313384.0 in 2022, then jumped by 60.73% to -$123072.0 in 2023, then soared by 594.44% to $608520.0 in 2024.
- The last three Other Non Operating Income figures came in at $608520.0 (Q4 2024), $717573.0 (Q3 2024), and -$9.7 million (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Moolec Science | 6.98 Bn | 6.98 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 608,520.00 |
| Sep 30, 2024 | 717,573.00 |
| Jun 30, 2024 | -9.74 Mn |
| Mar 31, 2024 | 1.13 Mn |
| Dec 31, 2023 | -123,072.00 |
| Sep 30, 2023 | 561,040.00 |
| Jun 30, 2023 | -13.67 Mn |
| Mar 31, 2023 | 86,120.00 |
| Dec 31, 2022 | -313,384.00 |
| Sep 30, 2022 | -3,111.00 |
| Jun 30, 2022 | -11.79 Mn |